Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-26 @ 1:10 AM
NCT ID:
NCT01124734
Group ID:
EG001
Title:
Course 1 Cycle 2
Description:
Patients will be given High-Dose Interleukin-2 (HD IL-2) 600,000 IU/kg, up to 14 doses at 8 hour intervals. On the day after discharge, patients will be given oral temozolomide at 75 mg/m2 daily for 21 days.
Interleukin-2: up to a maximum of 14 doses at 600,000 IU/kg
Temozolomide: Patients would receive temozolomide at 75 mg/m2 after discharge from receipt of the second cycle of high dose IL-2. Patients would take the medication at bedtime daily. Four weeks after cycle 2 of a course, they would take it for 21 days.
Deaths Number Affected:
9
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
17
Other Number Affected:
17
Other Number At Risk:
17
Study:
NCT01124734
Results Section:
NCT01124734
Adverse Events Module:
NCT01124734